Medigen Biotechnology Statistics

Total Valuation

TPEX:3176 has a market cap or net worth of TWD 4.33 billion. The enterprise value is 6.14 billion.

Market Cap	4.33B
Enterprise Value	6.14B

Important Dates

The last earnings date was Wednesday, November 12, 2025.

Earnings Date	Nov 12, 2025
Ex-Dividend Date	n/a

Share Statistics

TPEX:3176 has 139.31 million shares outstanding. The number of shares has decreased by -0.12% in one year.

Current Share Class	139.31M
Shares Outstanding	139.31M
Shares Change (YoY)	-0.12%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	11.12%
Owned by Institutions (%)	4.12%
Float	102.84M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	2.73
PB Ratio	0.88
P/TBV Ratio	2.80
P/FCF Ratio	n/a
P/OCF Ratio	70.80
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 67.80, with an EV/FCF ratio of -550.64.

EV / Earnings	-57.96
EV / Sales	3.87
EV / EBITDA	67.80
EV / EBIT	n/a
EV / FCF	-550.64

Financial Position

The company has a current ratio of 5.12, with a Debt / Equity ratio of 0.19.

Current Ratio	5.12
Quick Ratio	4.07
Debt / Equity	0.19
Debt / EBITDA	7.71
Debt / FCF	-83.46
Interest Coverage	-2.21

Financial Efficiency

Return on equity (ROE) is -3.80% and return on invested capital (ROIC) is -0.54%.

Return on Equity (ROE)	-3.80%
Return on Assets (ROA)	-0.49%
Return on Invested Capital (ROIC)	-0.54%
Return on Capital Employed (ROCE)	-0.91%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.24
Inventory Turnover	1.08

Taxes

In the past 12 months, TPEX:3176 has paid 106.29 million in taxes.

Income Tax	106.29M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -10.26% in the last 52 weeks. The beta is 0.33, so TPEX:3176's price volatility has been lower than the market average.

Beta (5Y)	0.33
52-Week Price Change	-10.26%
50-Day Moving Average	29.55
200-Day Moving Average	30.72
Relative Strength Index (RSI)	61.79
Average Volume (20 Days)	235,096

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, TPEX:3176 had revenue of TWD 1.59 billion and -105.96 million in losses. Loss per share was -0.76.

Revenue	1.59B
Gross Profit	882.46M
Operating Income	-51.51M
Pretax Income	-84.38M
Net Income	-105.96M
EBITDA	96.49M
EBIT	-51.51M
Loss Per Share	-0.76

Full Income Statement

Balance Sheet

The company has 2.37 billion in cash and 930.78 million in debt, giving a net cash position of 1.44 billion or 10.35 per share.

Cash & Cash Equivalents	2.37B
Total Debt	930.78M
Net Cash	1.44B
Net Cash Per Share	10.35
Equity (Book Value)	4.90B
Book Value Per Share	11.77
Working Capital	2.86B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 61.10 million and capital expenditures -72.25 million, giving a free cash flow of -11.15 million.

Operating Cash Flow	61.10M
Capital Expenditures	-72.25M
Free Cash Flow	-11.15M
FCF Per Share	-0.08

Full Cash Flow Statement

Margins

Gross margin is 55.62%, with operating and profit margins of -3.25% and -6.68%.

Gross Margin	55.62%
Operating Margin	-3.25%
Pretax Margin	-5.32%
Profit Margin	-6.68%
EBITDA Margin	6.08%
EBIT Margin	-3.25%
FCF Margin	n/a

Dividends & Yields

TPEX:3176 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	0.12%
Shareholder Yield	0.12%
Earnings Yield	-2.45%
FCF Yield	-0.26%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

TPEX:3176 has an Altman Z-Score of 2.56 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.56
Piotroski F-Score	4